Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$92.90 USD

92.90
4,102,103

-1.21 (-1.29%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $92.81 -0.09 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (91 out of 246)

Industry: Medical Services

Zacks News

Zacks Equity Research

Are Medical Stocks Lagging CVS Health (CVS) This Year?

Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.

Zacks Equity Research

SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System

Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair.

Zacks Equity Research

Reasons to Retain TransMedics Stock in Your Portfolio for Now

TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.

Zacks Equity Research

CVS Health (CVS) Laps the Stock Market: Here's Why

CVS Health (CVS) closed the most recent trading day at $67.58, moving +1.15% from the previous trading session.

Zacks Equity Research

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now

QDEL continues to witness growth on the back of its strong product portfolio.

Moumi Mondal headshot

Will CVS Health's Formulary Move Boost Its Weight Management Program?

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

Zacks Equity Research

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration

Beta Bionics collaborates with Abbott to integrate its iLet system with a dual sensor, aiming to simplify and enhance diabetes care.

Zacks Equity Research

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Smith+Nephew Stock May Gain From Strategic Deal With Standard Health

SNN teams with Standard Health to launch the United Kingdom's first orthopedic ASC, aiming to boost surgical efficiency and drive growth.

Zacks Equity Research

Here's Why You Should Retain Ecolab Stock in Your Portfolio Now

ECL continues to gain from its robust product portfolio and strong segmental performance.